TEVAR for aortic arch lesions combining physician-modified endograft and in-situ fenestration

CONCLUSIONS: Combining PMEG and ISF could be a feasible option for aortic arch lesions in selected patients. Long-term durability concerns require further evaluation.PMID:37962899 | DOI:10.23736/S0392-9590.23.05063-0

Source: International Angiology - November 14, 2023 Category: Cardiology Authors: Yuxi Zhao Zhaoxiang Zeng Xianhao Bao Mingwei Wu Jiaxuan Feng Zaiping Jing Rui Feng Source Type: research